Patents by Inventor Jose Vidal Torres

Jose Vidal Torres has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8029797
    Abstract: An anti-HIV vaccine composition is disclosed. The vaccine comprises an combination of immunogenic peptide mixtures, which mixtures may be prepared in a single synthesis. The composition collectively represents the in vivo variability seen in immunogenic epitopes from highly variable regions of HIV. Immunization with the vaccine elicits broadly reactive immunity (CTL and T helper cell responses) against the divergent strains of HIV upon which it is based. The vaccine may be formulated to target regionally distinct variability based on an HIV clade predominant in a geographical region.
    Type: Grant
    Filed: February 28, 2006
    Date of Patent: October 4, 2011
    Assignee: Variation Biotechnologies Inc.
    Inventors: José Vidal Torres, David Evander Anderson, Franscisco J. Diaz-Mitoma
  • Publication number: 20100121029
    Abstract: A process is disclosed for preparation of a immunogenic peptide mixture in a single synthesis. The peptide mixture collectively represents the in vivo variability seen in immunogenic epitopes from an HIV pathogen. The mixture is termed a hypervariable epitope construct (HEC). Immunization with a HEC evokes broadly reactive immunity against divergent strains of a pathogen upon which the HEC is based.
    Type: Application
    Filed: December 11, 2009
    Publication date: May 13, 2010
    Applicant: VARIATION BIOTECHNOLOGIES INC.
    Inventor: Jose Vidal Torres
  • Publication number: 20090117141
    Abstract: An anti-HIV vaccine composition is disclosed. The vaccine comprises an combination of immunogenic peptide mixtures, which mixtures may be prepared in a single synthesis. The composition collectively represents the in vivo variability seen in immunogenic epitopes from highly variable regions of HIV. Immunization with the vaccine elicits broadly reactive immunity (CTL and T helper cell responses) against the divergent strains of HIV upon which it is based. The vaccine may be formulated to target regionally distinct variability based on an HIV clade predominant in a geographical region.
    Type: Application
    Filed: February 28, 2006
    Publication date: May 7, 2009
    Applicant: VARIATION BIOTECHNOLOGIES INC.
    Inventors: Jose Vidal Torres, David Evander Anderson, Franscisco J. Diaz-Mitoma
  • Publication number: 20090104216
    Abstract: Peptide-based anti-influenza formulations against influenza A and B are disclosed. The peptides are derived from influenza-based epitopes. The formulations are based on peptide mixtures which may be formulated so that variability is present at particular residues. The formulations can be used to prepare vaccines for preventing influenza in human, avian, murine or equine animals.
    Type: Application
    Filed: June 1, 2006
    Publication date: April 23, 2009
    Applicant: Variation Biotechnologies, Inc.
    Inventor: Jose Vidal Torres
  • Patent number: 7118874
    Abstract: A process is disclosed for preparation of a immunogenic peptide mixture in a single synthesis. The peptide mixture collectively represents the in vivo variability seen in immunogenic epitopes from a pathogen. The mixture is termed a hypervariable epitope construct (HEC). Immunization with a HEC evokes broadly reactive immunity against divergent strains of a pathogen upon which the HEC is based.
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: October 10, 2006
    Assignee: Variation Biotechnologies Inc.
    Inventor: José Vidal Torres